Literature DB >> 7792787

Viability of partial liver graft from living donor in pigs.

H Katoh1, N Ohkohchi, T Hirano, M Sakurada, T Orii, N Koyamada, K Fujimori, M Takemura, T Endoh, S Satomi.   

Abstract

For evaluation of the viability of partial liver graft from a living donor, we investigated energy production of mitochondria and radical scavenging enzyme activities in partial and whole liver transplantation in pigs. The values of adenosine triphosphate (ATP) and total adenine nucleotide (TAN) of the partial liver graft were higher than those of the whole liver graft, whereas the hypoxanthine of the partial liver graft was lower than that of the whole liver graft. There was no statistical difference in the radical scavenging enzyme activities between the two groups. The values of respiratory control ratio (RCR) in both groups were above 3.0 and there was no statistical difference. The survival rates of pigs received partial liver and whole liver graft with 2 to 3 hr cold preservation was 71% and 91%, respectively and there was no statistical difference between two groups. These results suggest that viabilities of the partial liver graft from the living donor are satisfactory enough, compared with those of whole liver graft from a cadaver.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7792787     DOI: 10.1620/tjem.175.179

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  2 in total

1.  Effects of prolonged endotoxemia on liver, skeletal muscle and kidney mitochondrial function.

Authors:  Francesca Porta; Jukka Takala; Christian Weikert; Hendrik Bracht; Anna Kolarova; Bernhard H Lauterburg; Erika Borotto; Stephan M Jakob
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

2.  Norepinephrine to increase blood pressure in endotoxaemic pigs is associated with improved hepatic mitochondrial respiration.

Authors:  Tomas Regueira; Bertram Bänziger; Siamak Djafarzadeh; Sebastian Brandt; Jose Gorrasi; Jukka Takala; Philipp M Lepper; Stephan M Jakob
Journal:  Crit Care       Date:  2008-07-14       Impact factor: 9.097

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.